News in the past few years have not been positive about diabetes patients in the United States – the price of the medicine they need has been following a sad, upward trend. Thankfully, there might be some cheaper salvation for them – Eli Lilly is adding a new half-priced insulin brand to their portfolio.
The new product titled ‘Lispro’ is set to sell for $137 for
Generic medicines are common in the United States, but insulin shots were not among them until now. Experts believe that the introduction of a generic-brand insulin shot might be a step in the right direction when it comes to controlling medication prices. In addition to this, it should substantially help those diabetes patients who do not purchase insulin via their health insurance benefits.